Active

Andy Warhol, Flowers (F&S II 6)

Asset value
63.450 €
Issue price per Splint
50 €
Total number of Splints
1.269
Investment horizon in years
2 to 4
Return-to-Risk Assessment
8/10
Since launch July ‘25
+0.0%

Main reasons to invest

  • Return Potential📈: An investment of €500 could reach an estimated value of €1,211 in 4 years.

  • Cost-to-Return Ratio⚖️: With just 2.3% annual total costs (July / August releases with no exit fees), your net profit could be 24.7% per year.

  • Everyday Joy from a Timeless Masterpiece 🌸: Warhol’s “Flowers” radiate color, optimism, and cultural edge—bringing the energy of 1960s New York into your space. This print evokes both artistic legacy and emotional uplift, offering a daily reminder of creativity, beauty, and the enduring power of simplicity. A truly personal icon from the Pop Art movement.

Description

Valuation Summary 📝

1. Strong Return Opportunity Supported by Market Data
This investment targets a 2–4 year holding period, drawing on robust historical growth and strong recent sales data from Warhol’s “Flowers” series.

Balanced Scenario (CAGR, 2025–2028):
→ €153,639 | CAGR: 24.7% p.a.

Ambitious Scenario:
→ €221,869 | CAGR: 36.7% p.a.

With 46 comparable transactions, a projected net ROI of 22.3% p.a. in the base case confirms the strength of Warhol’s market traction. This outpaces the SMI’s Sharpe benchmark of 0.61 and supports strong capital appreciation potential for mid-term investors.


2. Risk Profile and Volatility Benchmarking
Volatility analysis using comparables like Banksy and the ArtPrice100 Index yields a standard deviation of 31.0%.
Value at Risk (VaR): There is a 75% probability the asset’s value will exceed €80,500 after three years, providing downside protection relative to the initial acquisition.
Maximum drawdown risk is estimated at -20%, illustrating resilience in periods of market correction.


3. Entry with Validated Fair Value
Acquired for €58,100, this Warhol print enters at a 16% discount to the lowest gallery listings. The work’s pristine condition and provenance—from Leo Castelli and Susan Sheehan—reinforce its premium market positioning. This pricing edge offers a compelling margin of safety and long-term upside.


4. Rarity, Exclusivity, and Collector Validation
Flowers (F&S II.6) is a 1964 hand-signed print directly tied to Warhol’s landmark solo show at Leo Castelli Gallery. As one of the artist’s most institutionally recognized series, the Flowers prints have become cultural symbols. The artwork’s exceptional preservation and historical context make it a collector-grade investment with enduring value.


5. Interesting Facts
- First exhibited in Warhol’s 1964 solo show at Leo Castelli Gallery
- Direct provenance from Castelli and Susan Sheehan Galleries
- Hand-signed and dated by Andy Warhol
- Pristine 1964 print, edition of 300, 56 x 56 cm
- Offset lithograph in colour on wove paper
- Flowers series: shown at top institutions and highly collected
- Warhol is one of the world’s top five most traded artists across all categories

Why Invest in This Category? 🎨
Art has delivered consistent returns for collectors over centuries. Warhol’s iconic status and global recognition ensure high liquidity, while blue-chip works like Flowers are backed by strong institutional validation and collector demand. Investing in art combines financial return with cultural significance and portfolio diversification.
Why Invest in This Asset? 💎

Andy Warhol’s “Flowers” series holds an iconic place in 20th-century art history—both conceptually and commercially. This specific print, “Flowers (F&S II.6),” is a 1964 offset lithograph, hand-signed by Warhol, and linked directly to his pivotal solo show at the Leo Castelli Gallery. Priced at £50,000, it presents an accessible entry into Warhol’s blue-chip market segment, particularly given its exceptional condition and origin.

From 1964 to today, Warhol’s Flowers have bridged Pop Art’s cultural disruption with institutional acceptance, transitioning from Castelli’s walls to MoMA’s permanent collections. The upcoming 12–24 month market cycle offers ideal timing. Given the increasing scarcity of well-preserved editions and the cultural currency Warhol continues to hold, this asset benefits from built-in momentum. Conservative projections show 20% growth; balanced at 28%; ambitious scenarios at 40%. These targets are well supported by comparable pricing trends.

Warhol’s “Flowers” embody the power of post-war repetition and Pop reinterpretation—bold yet meditative. With direct provenance from institutions that defined American modernism, this edition is more than a decorative work; it’s a strategic acquisition. Coupled with Warhol’s immense cultural gravitas and the continued rise in global Pop Art transactions, the piece offers not just historical resonance, but the kind of scarcity, liquidity, and condition profile typically reserved for seven-figure assets. It’s a collector-grade opportunity with financial upside.

Conclusion 🎯
This museum-worthy Warhol offers investors the trifecta of condition, provenance, and pricing advantage—making it a timely and compelling opportunity in today’s fine art market.

Expert

Zurani - Art Asset Management

Zurani caters to the distinct needs of family offices, wealth managers, and UHNWIs implementing investment strategies in the art market. Our expertise lies in assisting investors in navigating the global art market and optimising their portfolios. Our core services include market analysis, acquisitions, advisory services, portfolio management, risk management and estate planning. We educate partners on the opportunities and challenges of art as an asset class. Our approach is centred on understanding each partner's unique needs and providing tailored solutions accordingly.

Additional details

Asset ID
b84be080-40a6-4b08-ad57-2608546b78f5
Name
Flowers (F&S II 6)
Artist
Andy Warhol
Publication year
1964
Size
56 x 56 cm
Number of editions
300
Signature
Hand signed and dated by the artist
Material
Offset Lithograph printed in colours on wove paper

Documents

Aurelio Image CEO

Aurelio

CEO & Co-Founder